Upregulation of miR-135b is involved in the impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients.
Previous studies have demonstrated that mesenchymal stem cells from multiple myeloma (MM) patients (MM-hMSCs) display a distinctive gene expression profile, an enhanced production of cytokines and an impaired osteogenic differentiation ability compared to normal donors (ND-hMSCs). However, the under...
Main Authors: | Song Xu, Gaia Cecilia Santini, Kim De Veirman, Isabelle Vande Broek, Xavier Leleu, Ann De Becker, Ben Van Camp, Karin Vanderkerken, Ivan Van Riet |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3819242?pdf=render |
Similar Items
-
Histone deacetylase inhibitors in multiple myeloma
by: Sarah Deleu, et al.
Published: (2009-06-01) -
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma
by: Kim De Veirman, et al.
Published: (2014-06-01) -
An Improved Harvest and in Vitro Expansion Protocol for Murine Bone Marrow-Derived Mesenchymal Stem Cells
by: Song Xu, et al.
Published: (2010-01-01) -
The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma
by: Sylvia Faict, et al.
Published: (2019-11-01) -
Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma
by: Elke De Bruyne, et al.
Published: (2013-04-01)